Device maker Novocure said that the Food and Drug Administration approved its first-of-a-kind treatment that fights cancerous brain tumors using electrical energy fields.
U.S.-Swiss medical device maker Synthes Inc. confirmed it is in talks to be bought out by health giant Johnson & Johnson, in a deal that could make its chairman Switzerland's richest man.
Eli Lilly and Co.'s first-quarter profit fell 15 percent because of severance costs and a diabetes drug development agreement designed to help the drugmaker handle a wave of patent expirations for key products.
Vince & Associates Clinical Research, Overland Park, Kan., has opened a 90-bed Clinical Pharmacology Research Unit.
The Z Axis Motorized Stage from Prior Scientific offers a wide range of positioning solutions for a variety of applications. Many configurable options are available from a simple motorized linear axis to a full three axis stage system.
Zinsser Analytic has developed µFRACS – an automated low volume fraction collector for µHPLC. µFRACS is a rapid and accurate system that quickly collects small fractions of only a few µLs directly into 384-well or 96-well microtiter plates.
Recently retired Merck & Co. CEO Richard Clark saw a 65 percent increase in total compensation last year compared with 2009, when stock price fluctuations reduced stock and option awards given to the drugmaker's top executives.
Pfizer Inc. announced top-line results from the ORAL Scan Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor.
Eight genes which control levels of the main steroid produced by the adrenal gland, believed to play a role in ageing and longevity, have been uncovered by an international consortium of scientists.
An enzyme essential for DNA replication and repair in humans works in a way that might be exploited as anti-cancer therapy, say researchers at The Scripps Research Institute and Lawrence Berkeley National Laboratory.
Amylin Pharmaceuticals, Inc. announced results from a new analysis of an ongoing, long-term research study of the investigational drug metreleptin, an analog of the human hormone leptin, for the treatment of lipodystrophy.
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said a European committee has endorsed its potential diabetes treatment Bydureon, a key step toward possible approval in the European Union.
Drugmakers Merck and Johnson & Johnson said they've reached a deal to end a multibillion dollar arbitration dispute over rights to two lucrative drugs for immune disorders.
Johnson & Johnson issued yet another recall , this one for about 57,000 bottles of a widely used epilepsy pill, due to complaints of a chemical odor. The health care giant said it is recalling two lots of 100-milligram tablets of Topamax.
Affymetrix, Inc. launched the Axiom Genome-Wide CHB 1 Array, the first commercial product to maximize genetic coverage of common alleles in Han Chinese populations. This array is the third population-designed array for the Axiom Genotyping Solution.